K. Otani
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
- Psychiatry and Mental health top 2%
- Epilepsy research and treatment
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Schizophrenia research and treatment 12
- Bipolar Disorder and Treatment 11
- Epilepsy research and treatment 8
- Pharmacology 11
- Pharmacogenetics and Drug Metabolism 10
- Treatment of Major Depression 7
- Drug-Induced Hepatotoxicity and Protection 4
- Co-authors
- Shuji Kaneko (25 shared papers)Akihito Suzuki (19 shared papers)Y. Fukushima (9 shared papers)Tsuyoshi Kondo (17 shared papers)Tomoko Hirano (6 shared papers)Kazuo Mihara (16 shared papers)Takashi Fukasawa (4 shared papers)Motohiro Okada (3 shared papers)
- Journals
- International Clinical Psychopharmacology (7 papers)European Journal of Clinical Pharmacology (6 papers)Therapeutic Drug Monitoring (5 papers)Human Psychopharmacology Clinical and Experimental (4 papers)European Psychiatry (2 papers)
- Partner nations
- JapanUnited StatesSweden
In The Last Decade
K. Otani
49 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 88
- Pharmacology 242
- Psychiatry and Mental health 365
- Biological Psychiatry 42
- Horticulture 18
- Cellular and Molecular Neuroscience 249
Countries citing papers authored by K. Otani
This map shows the geographic impact of K. Otani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Otani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Otani more than expected).
Fields of papers citing papers by K. Otani
This network shows the impact of papers produced by K. Otani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Otani. The network helps show where K. Otani may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Otani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 145 | |
| 2 | 1991 | 84 | |
| 3 | 2007 | 82 | |
| 4 | 1992 | 77 | |
| 5 | 2002 | 74 | |
| 6 | 2001 | 57 | |
| 7 | 1995 | 48 | |
| 8 | 1995 | 45 | |
| 9 | 2004 | 32 | |
| 10 | 1997 | 30 | |
| 11 | 1996 | 26 | |
| 12 | 2005 | 25 | |
| 13 | 1989 | 25 | |
| 14 | 2011 | 25 | |
| 15 | 1994 | 24 | |
| 16 | 2001 | 21 | |
| 17 | 1992 | 20 | |
| 18 | 1990 | 19 | |
| 19 | 2014 | 17 | |
| 20 | 1997 | 17 |
About K. Otani
K. Otani is a scholar working on Psychiatry and Mental health, Pharmacology, Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (12 papers), Bipolar Disorder and Treatment (11 papers), Pharmacogenetics and Drug Metabolism (10 papers), Epilepsy research and treatment (8 papers), Treatment of Major Depression (7 papers), Pharmacological Effects and Toxicity Studies (6 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). The work is most often cited by research in Pharmacology (242 citations), Psychiatry and Mental health (365 citations), Biological Psychiatry (42 citations), Horticulture (18 citations) and Cellular and Molecular Neuroscience (249 citations). K. Otani has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Shuji Kaneko, Akihito Suzuki, Y. Fukushima, Tsuyoshi Kondo, Tomoko Hirano, Kazuo Mihara, Takashi Fukasawa, Motohiro Okada, M. Ishida and K. Sugawara. Their work appears in journals such as International Clinical Psychopharmacology, European Journal of Clinical Pharmacology, Therapeutic Drug Monitoring, Human Psychopharmacology Clinical and Experimental and European Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.